http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102014024940-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_277318fc88960f0d09b0246e131d8f1e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49aa61f7fa17a00eea3cf7ea0e22616a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cf4f83fb7fd56daf2753bee5ce8248 |
| publicationDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102014024940-A2 |
| titleOfInvention | ANTITUMORAL COQUETTE COMPREHENDING AN SELECTIONAL ANTITUMOR AGENT FOR TUMOR ACIDITY, AN ANTIOXIDANT AND AN INHIBITOR OF GLYCOPROTEIN P |
| abstract | An antitumor cocktail comprising an oral tumor acid selective antitumor agent, an antioxidant and a glycoprotein inhibitor presently refers to an antitumor cocktail comprising a combination of a commercial antitumor drug (1), such as 9-acridine carboxylic acid, associated with to an antioxidant (2) such as coenzyme-qlo and a p-glycoprotein inhibitor (3) such as metformin, ketoconazole, quinidine, varapamil, cyclosporazole, ketoconazole, erythromycin, spironolactone, itraconazole, tariquidar, zozuquidar, eliquridar, laniquidar , ontogen, imidazole, anthranilamide, dexveraparnil and / or dexniguldipine, to selectively destroy solid tumor cells without affecting rapidly replicating healthy cells. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020181802-A1 |
| priorityDate | 2014-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.